Literature DB >> 16927135

Marked decrease of serum Ca 125 levels after Denver shunt placement in a patient with cirrhosis and refractory ascites.

L Leggio1, L Abenavoli, C D'Angelo, A Ferrulli, L Vonghia, A Mirijello, R Barbarino, T De Michele, C Zuppi, D Gui, G L Rapaccini, G Gasbarrini, G Addolorato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16927135     DOI： 10.1007/s10620-006-9115-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  14 in total

1.  Re. Zuckerman et al.--Sensitivity of CA-125 in patients with liver cirrhosis in the presence of ascites.

Authors:  R Sari; B Yildirim; A Sevinc; F Hilmioglu
Journal:  Am J Gastroenterol       Date:  2001-01       Impact factor: 10.864

2.  Cancer antigen 125: a sensitive marker of ascites in patients with liver cirrhosis.

Authors:  E Zuckerman; A Lanir; E Sabo; T Rosenvald-Zuckerman; I Matter; D Yeshurun; S Eldar
Journal:  Am J Gastroenterol       Date:  1999-06       Impact factor: 10.864

3.  Elevation of CA 125 in patients with benign and malignant ascites.

Authors:  J F Bergmann; J M Bidart; M George; M Beaugrand; V G Levy; C Bohuon
Journal:  Cancer       Date:  1987-01-15       Impact factor: 6.860

Review 4.  Markedly elevated CA125 in hepatic cirrhosis: two case illustrations and review of the literature.

Authors:  J K DiBaise; J P Donovan
Journal:  J Clin Gastroenterol       Date:  1999-03       Impact factor: 3.062

Review 5.  Diagnosis of abdominal tuberculosis: experience from 11 cases and review of the literature.

Authors:  Ali Uzunkoy; Muge Harma; Mehmet Harma
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

6.  Elevation of CA-125 level is due to abdominal distension in liver transplantation candidates.

Authors:  M Deschênes; R P Michel; E Alpert; J S Barkun; P Metrakos; J Tchervenkov
Journal:  Transplantation       Date:  2001-11-15       Impact factor: 4.939

Review 7.  How to interpret serum CA 125 levels in patients with serosal involvement? A clinical dilemma.

Authors:  Alper Sevinc; Celalettin Camci; H Mehmet Turk; Suleyman Buyukberber
Journal:  Oncology       Date:  2003       Impact factor: 2.935

8.  Serum tumor markers in chronic liver disease.

Authors:  A Kadayifci; H Simsek; M C Savas; M Toppare
Journal:  Neoplasma       Date:  1996       Impact factor: 2.575

9.  Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases.

Authors:  R Molina; X Filella; J Bruix; P Mengual; J Bosch; X Calvet; J Jo; A M Ballesta
Journal:  Clin Chem       Date:  1991-08       Impact factor: 8.327

10.  Elevation of serum and ascites cancer antigen 125 levels in patients with liver cirrhosis.

Authors:  Wen-Bin Xiao; Yu-Lan Liu
Journal:  J Gastroenterol Hepatol       Date:  2003-11       Impact factor: 4.029
View more
  1 in total

1.  The Significance of Serum CA-125 Elevation in Chinese Patients with Primary Budd-Chiari Syndrome: A Multicenter Study.

Authors:  De-Lei Cheng; Hao Xu; Wei-Fu Lv; Rong Hua; Hongtao Du; Qing-Qiao Zhang
Journal:  Gastroenterol Res Pract       Date:  2015-09-15       Impact factor: 2.260
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.